ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,193 | -31.6% | 20,250 | +31.1% | 0.00% | -100.0% |
| Q2 2023 | $330,630 | -47.1% | 15,450 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $624,798 | -11.6% | 15,450 | +1.6% | 0.00% | -50.0% |
| Q4 2022 | $707,104 | -61.3% | 15,200 | -56.9% | 0.00% | -60.0% |
| Q3 2022 | $1,829,000 | +13.5% | 35,270 | +3.5% | 0.01% | +25.0% |
| Q2 2022 | $1,611,000 | -40.6% | 34,084 | -10.5% | 0.00% | -33.3% |
| Q1 2022 | $2,712,000 | -4.8% | 38,095 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $2,849,000 | +140.0% | 38,095 | +82.3% | 0.01% | +150.0% |
| Q3 2021 | $1,187,000 | +29.0% | 20,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $920,000 | -8.5% | 20,900 | +2.5% | 0.00% | 0.0% |
| Q1 2021 | $1,006,000 | +41.5% | 20,400 | +20.7% | 0.00% | 0.0% |
| Q4 2020 | $711,000 | -8.1% | 16,900 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $774,000 | -8.8% | 16,900 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $849,000 | -2.3% | 16,900 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $869,000 | -5.6% | 16,900 | +13.4% | 0.00% | +50.0% |
| Q4 2019 | $921,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |